N=1 协作任命休·亨佩尔为第一任执行主任,负责推进罕见疾病治疗和促进全球协作。 N=1 Collaborative appoints Hugh Hempel as first Executive Director to advance rare disease therapies and promote global collaborations.

N=1合作组织(N1C)已任命休·赫姆佩勒为首任执行主任。 The N=1 Collaborative (N1C) has named Hugh Hempel as its first Executive Director. 在稀有疾病保健方面,Hempel具有丰富背景,将牵头努力增加稀有疾病患者获得治疗的机会,并促进个人化医学发展的全球协作。 With a strong background in rare disease healthcare, Hempel will lead efforts to enhance access to therapies for rare disease patients and promote global collaborations for individualized medicine development. 他的领导能力旨在使保健领域的利益攸关方参与,为遗传治疗建立标准化框架。 His leadership aims to engage stakeholders across the healthcare spectrum to create standardized frameworks for genetic treatments.